enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. STAMPEDE (clinical trial) - Wikipedia

   en.wikipedia.org/wiki/STAMPEDE_(clinical_trial)

   STAMPEDE (clinical trial) Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) is a clinical trial investigating treatments for high risk or terminal prostate cancer. Recruitment started in 2005 and ended in 2022; as of January 2020, over 10,000 participants had joined the trial.

3. Prostate cancer - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer

   Five-year survival rates range from 30–99%, depending on stage. [1] Prostate cancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder. Abnormal growth of prostate tissue is usually detected through screening tests, typically blood tests that check for prostate-specific antigen (PSA ...

4. Management of prostate cancer - Wikipedia

   en.wikipedia.org/wiki/Management_of_prostate_cancer

   Bisphosphonates such as zoledronic acid have been shown to delay skeletal complications such as fractures or the need for radiation therapy in patients with hormone-refractory metastatic prostate cancer. [84] Xofigo is a new alpha-emitting pharmaceutical targeting bone metastasis. Phase II testing shows prolonged patient survival times, reduced ...

5. This Unexpected Pain Is a Common Sign of Prostate Cancer ...

   www.aol.com/lifestyle/unexpected-pain-common...

   In fact, the ACS puts the five-year survival rate for local and regionalized prostate cancer at about 99%. Understanding your risk and signs and symptoms of prostate cancer can be life-saving.

6. Metastatic Prostate Cancer: Symptoms, Medications and More - AOL

   www.aol.com/news/metastatic-prostate-cancer...

   The number of new cases of metastatic, or stage 4, prostate cancer shot up 72 percent between 2004 and 2013, according to the Northwestern Medicine study. Overall, one in nine men in the U.S. will ...

7. Prostate cancer shouldn’t be a death sentence. But for a ...

   www.aol.com/finance/prostate-cancer-shouldn-t...

   In fact, the five-year survival rate for prostate cancer detected early is virtually 100%, Siddiqui says. The outlook for late-diagnosed patients, however, is not nearly as rosy.